Founder and CEO Jacques Dikansky said in press reports that 4-5 acquisitions were likely in 2012 to go with the 10 it took possession of in the past decade, including French supplier Burgundy and Polish player Pektowin in the past three months.
Its biggest acquisition was the €110m deal with Spanish firm Natraceutical which doubled its revenue in 2009.
Delivering its 2011 financials today, Naturex saw 2011 exchange rate-adjusted sales surge 12.3% to €253.6m, from €226.3 in 2010.
“We are very satisfied with this excellent year of growth, marked by the positive orientation of all of our activities and geographic zones. The integration of Burgundy is now on the road to completion and our teams are working actively to quickly develop the commercial synergies.” Dikansky said.
“With our strengthened geographic positioning, the highly favourable acceptance of our new product ranges and our industrial and scientific expertise, we are confident in our ability to continue to outperform the future growth of our markets.”
Q4 sales were the lowest for the year at €62.4m – 12% up on 2010.
Burgundy contributed €2.7m to sales, including €2.3m in the Nutrition & Health division and €0.4m in Personal Care.
Sales were broken down between Food & Beverage (€153.4m – up 11.9%); Nutrition & Health (€84.5m – up 11.9%); Personal Care (€3m - up 11%).
In unadjusted figures, sales in Asia and Oceania grew the fastest at 16.7% to reach €28.56m, compared to €92.5m for the Americas (up 10%) and a 10.3% gain in Europe to €129.78m.
The company noted three new offices in 2011 meant it had locations in 18 countries.